|
James
P. Landers, Ph.D.
 |
|
Professor of Chemistry
Associate Professor of Clinical Chemistry
1991: Canadian Medical Research Fellow,
Mayo Clinic
1988: Ph.D.
Biochemistry, University
of Guelph, Canada
1983: B.S.
Biochemistry, University
of Guelph, Canada
|
|
Biography
Dr.
Landers received his Bachelor of Science
degree in Biochemistry with a minor in Biomedicine at the University of
Guelph (Ontario,
Canada) in 1983. He received his doctorate in Biochemistry (with
distinction) in 1988 from the Department of Chemistry and Biochemistry
at the same University. After a post-doctoral fellowship at the Banting
Institute in the School of Medicine at the University of Toronto in
1989, he received a Medical Research Council Fellowship to study with
Dr. Thomas Spelsberg at the Mayo Clinic. In Spelsberg's laboratory, he
explored new state-of-the-art bioanalytical technologies for developing
rapid, sensitive assays for disease diagnosis. At the end of the
post-doctoral fellowship (1993), he remained at the Mayo Clinic as the
Director of Clinical Capillary Electrophoresis Facility which was
established in the Department of Laboratory Medicine and Pathology. His
group was involved in the exploration, development and implementation
of a number of routine and esoteric CE-based assays for diagnosis of
disease. These included separation-based assays for multiple myeloma,
amyloidosis, multiple sclerosis, hypoglycemic drug abuse, kidney
function, and alcoholism, to name a few. He moved his program to the
University of Pittsburgh in 1997, where he filled the position of an
Assistant Professor in the Analytical Division of the Department of
Chemistry and adjunct member of the University of Pittsburgh Cancer
Center. In 1999, he accepted a position at the University of Virginia
and currently serves as a Professor in the Department of Chemistry and
as a Professor of Pathology in the University of Virginia Health
Sciences Center.
[Click
here for Dr. Landers's Dept. of Chemistry Biography]
|
(back to top)
Jerome P. Ferrance,
Ph.D.
 |
|
1996: Ph.D. Chemical
Engineering, University of Pittsburgh
Dissertation: "Development of General Model
for Coal Liquefaction"
1987: M.S. Chemical
Engineering, University of Pittsburgh
Thesis: "Testing of a System Designed to
Monitor the Chloride Channel of the GABA Receptor"
1985: B.S.E. Chemical
Engineering, Magna
Cum Laude,
University of Pittsburgh
|
|
Recent
Research
Current
research efforts
are focused on the development of
microfluidic devices and instrumentation for detection and analysis of
biomarkers specific for the diagnosis, prognosis and therapeutic
monitoring of
cancer from fine needle biopsies.
This
development involves the design and fabrication of new chromatographic
media
for implementation in microfluidic devices used for immobilization of
proteins
for affinity chromatographic capture of biomarkers.
The new media allows for direct on-column
detection of the captured proteins using sandwich type assays as well
as
interrogation to determine the extents of post-translational
modifications.
A
second
part of this project involves the design and construction of bench top
laser
induced fluorescence detection systems for use with the microfluidic
devices. This
project uses low cost
diode lasers excitation, coupled to photodiode based detection,
employing
optical technology for decreasing the background to promote the
sensitivity of
the detection.
[Click
here for more information about Dr. Ferrance]
|
(back to top)
Lindsay Legendre,
Ph.D.
 |
|
2007: Post-doctoral Fellow, University of Virginia
2007: Ph.D. Bioanalytical Chemistry, University of Virginia
2002: B.S. Chemistry & Mathematics, Richard Stockton College of New Jersey
Click
here for Lindsay's complete CV
|
|
A Fully Integrated Microfluidic Genetic Analysis Device for the Detection of Blood Cancers
We are developing
a fully-integrated microdevice capable of DNA extraction, PCR
amplifciation and the subsequent electrophoretic separation
specifically for the detection of T-cell lymphoma (TCL). While we
have recently reported a fully-integrated device for the detection of
bacteria [1], the interrogation of human genomic DNA from whole blood
provides new challenges, especially when detecting gene rearrangements
correlative with cancer. Detection of TCL involves the PCR
amplification of select sequences in the T-cell gene that are likely to
have undergone gene rearrangment. These PCR fragments represent a
polyclonal cell population in normal individuals and a monoclonal cell
population in patients with lymphoma in a way that can be discriminated
by electrophoretic separation. In clinical labs, the PCR that
follows DNA extraction requires ~3 hours followed by a 40 min capillary
electrophoresis separation under single-stranded conditions and
utilizing 4-color detection. While integration of procressing
steps is a large advantage over traditional methods, the reduction in
the times associated with these lengthy processes is also an important
benefit.
[1]
Easley, C.J., Karlinsey, J.M., Bienvenue, J.M., Legendre, L.A., Roper,
M.G., Feldman, S.H., Hughes, M.A., Merkel, T.J., Ferrance, J.P.,
Landers, J.P. Proc. Natl. Acad. Sci. USA, 2006, 109(51), 19272-19277.
DNA Extraction and PCR Amplification Performed in a Single Microfluidic Chamber
Integrated
microdevices provide the opportunity to encompass multiple analytical
steps on a single device, with the possibility of automating the entire
sample analysis process. Current work being developed involves a glass
microdevice that has been designed to perform solid phase extraction
(SPE) of DNA and IR-PCR (infrared-mediated) amplification in a novel
format - with both processes in the same chamber. This provided
an inherent advantage over any microchip-based DNA extract described
previously, [1] in that all of the sample DNA is used for nanoliter
amplification, improving detection limits by 1-2 orders of magnitude.
A novel solid phase, chitosan-coated magnetic beads, has been
developed that has high DNA recoveries (72% ± 6%) using a
pH-induced DNA release technique, [2] while eliminating the use of high
salt solutions and organics (both potent PCR inhitbitors). A
simple external magnet is used to control the location of the beads in
the chamber, removing the need for etching structures (such as weirs or
pillars) into the cahnnels, increasing the simplicity of the device
design and fabrication. While previous SPE phases have been
composed of materials incompatible with PCR [1] (due to high protein
adsorption) the chitosan coating does not affect the efficiency of PCR,
allowing the beads to remain in the very same chamber used for PCR.
[1] Legendre, L.A., Bienvenue, J.M., Roper, M.R., Ferrance, J.P., Landers, J.P. Analytical Chemistry, 2006, 78, 1444.
[2] Cao, W., Easley, C.J., Ferrance, J.P., Landers, J.P. Analytical Chemistry, 2006, 78, 7222-7228.
In 2008, Lindsay will begin the Postdoctoral Training Program in Clinical Chemistry and Laboratory Medicine at the Department of Pathology at the University of Virginia.
|
(back to top)
Jian
Wen
(back to top)
Dan
Marchiarullo
Jessica Voorhees
Norris
 |
|
2003-Present: Ph.D. candidate,
University of Virginia
2002: M.Sc.
Forensic Science, King's
College, University of
London, UK
1999: B.S. Biology,
minor
Chemistry, College of William & Mary
Click
here for Jessica's complete
CV
|
|
Cell
Sorting for Forensic and Genetic Analysis
Differential
extraction (DE) is a well-established technique for the
recovery and
separation
of biological materials from cotton swab samples taken from sexual
assault
victims. However, this procedure is time consuming, and has
contributed
to a backlog of forensic casework samples involving biological
evidence. In
addition, DE is often ineffective for samples containing sperm cells as
a minor
component in the presence of excess epithelial cells, resulting in
mixed STR
profiles that are often difficult to interpret.
My research focuses on
the improvement
of conventional DE methods to increase the purity of the
male
fraction and enhance the overall speed of analysis.
In addition, my work involves integration of
cell sorting with downstream analytical processes in an
effort to
develop a
fully-integrated microdevice capable of genetic DNA analysis.
|
(back to top)
Ling
Huang
 |
|
2004-Present: Graduate student,
University of Virginia
2004: M.S.
Analytical Chemistry, University of Oklahoma
2001: B.S.
Chemistry, Fudan Univesrity, Shanghai, China
|
|
Elastomer-based
Chemo-Mechanical Sensor
This
is a collaborative project with Dr. Matt Begley's lab (http://people.virginia.edu/~mrb3h/)
in the Civil Engineering Dept. of UVa. Elastomer-based freestanding
structure was theoretically demonstrated to be highly sensitive
compared to conventional Si-based freestanding structures. The main
idea is to develop chemically-selective surfaces on ultra-compliant
polymeric microstructures: selective adsorption of molecules leads to
mechanical deformation or
¡°buckling¡± that can be used to
indicate the
presence of pollutants, pathogens, cancer markers, etc.
We have
microfabricated freestanding cantilevers, and membranes, and macro
scaled elastomer strips to prove the concept of the elastomer-based
chemo-mechanical sensing. Protein-substrate interaction (e.g.
Avidin-Biotin), DNA-salt interaction have been applied on the
freestanding structures. The biological and physical effects of protein
and DNA behaviors on surface as well as the surface mechanics can be
elucidated besides the sensing application. Various surface
functionalization techniques are being explored.
Electric-Field
Flow Fractionation for DNA Concentration
In
many
separation scenarios, a simple preconcentration step between
purification steps is highly desired. For example, the elution step on
a
microchip solid phase extraction column dilutes the DNA and raises the
threshold for downstream amplifications. To solve this problem, we are
developing electric field-flow based glass/PDMS microdevices to recover
concentrated DNA samples from upstream extraction/purification steps.
|
(back to top)
Dan
Leslie
(back to top)
Kristin
Hagan
 |
|
2005-Present: Graduate
student, University of Virginia
2001-2005: B.S.
Chemistry, James
Madison
University
Click
here for Kristin's complete CV |
|
Nucleic
Acid Purification
My
current research focus involves RNA extraction
on a microdevice as a
purification step for mRNA profiling for genetic analysis and clinical
diagnosis. A silica-based method has been developed for RNA
purification,
and has demonstrated effective extraction of RNA from biological
samples such
as semen and semen stains. Alternatives
to silica-based phases are being
explored for their potential for both RNA and DNA purification. DNA
extraction
from biological sources is another area of focus in my research, using
silica-based methods as well as SPE
methods
using a charge switch technology developed in our lab, which avoids the
use of
PCR inhibitors. This new SPE matrix is based on the pH-dependent charge
of
chitosan, allowing for the capture and release of DNA using buffers
that differ
in pH. Work with these and other phases encompasses my
research toward
the development of a system for total nucleic acid purification from
biological
samples.
|
(back to top)
Carmen
Reedy
(back to top)
Alison
Dewald
 |
|
2006-Present: Graduate student,
University of Virginia
2006: M.Ed.,
Temple University
2001: B.S.
Chemistry, Penn
State University
2001: B.S.
Secondary Education, Penn State University |
|
Recent
Research
Protein
Separation
|
(back to top)
[The
information above is for reference only and should not be reproduced in
any
form.]
|
 |
 
|
|